Golden State Equity Partners Mereo Biopharma Group PLC Transaction History
Golden State Equity Partners
- $491 Million
- Q1 2025
A detailed history of Golden State Equity Partners transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Golden State Equity Partners holds 19,900 shares of MREO stock, worth $51,541. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,900
Previous 22,600
11.95%
Holding current value
$51,541
Previous $79,000
44.3%
% of portfolio
0.01%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding MREO
# of Institutions
97Shares Held
117MCall Options Held
151KPut Options Held
455K-
Janus Henderson Group PLC London, X017.1MShares$44.3 Million0.03% of portfolio
-
Rubric Capital Management LP New York, NY15.3MShares$39.6 Million0.89% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.6MShares$24.9 Million1.34% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.72MShares$22.6 Million0.06% of portfolio
-
Mangrove Partners New York, NY8.64MShares$22.4 Million4.71% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $324M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...